VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) saw strong trading volume on Friday . 58,830 shares were traded during trading, a decline of 56% from the previous session’s volume of 133,998 shares.The stock last traded at $93.29 and had previously closed at $92.63.
VanEck Pharmaceutical ETF Stock Performance
The company’s 50-day moving average is $91.57 and its 200 day moving average is $89.08. The company has a market capitalization of $620.77 million, a PE ratio of 21.04 and a beta of 0.72.
VanEck Pharmaceutical ETF Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Friday, July 5th. Investors of record on Monday, July 1st were given a $0.3558 dividend. The ex-dividend date of this dividend was Monday, July 1st.
Hedge Funds Weigh In On VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF Company Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Stories
- Five stocks we like better than VanEck Pharmaceutical ETF
- Insider Trades May Not Tell You What You Think
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- How to Use the MarketBeat Stock Screener
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.